» Articles » PMID: 22006170

Dendritic Cells: Novel Players in Fibrosis and Scleroderma

Overview
Publisher Current Science
Specialty Rheumatology
Date 2011 Oct 19
PMID 22006170
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells are professional antigen-presenting cells that are most studied for their function in mediating T-cell tolerance and T-cell activation. In addition, recent evidence indicates that dendritic cells can regulate the vasculature and function of fibroblast-type cells. The potential contribution of dendritic cells to scleroderma and fibrosis is not well-understood. In this article, we review recent studies as well as describe our own ongoing work that points toward a role for dendritic cells in scleroderma and fibrosis.

Citing Articles

Fibrostricturing Crohn's Disease Is Marked by an Increase in Active Eosinophils in the Deeper Layers.

Jacobs I, Ke B, Ceulemans M, Cremer J, dHoore A, Bislenghi G Clin Transl Gastroenterol. 2024; 15(7):e00706.

PMID: 38690831 PMC: 11272291. DOI: 10.14309/ctg.0000000000000706.


Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis.

Bhatt H, Diwan R, Estevao I, Dong R, Smith J, Xiao C J Control Release. 2024; 370():110-123.

PMID: 38648957 PMC: 11705614. DOI: 10.1016/j.jconrel.2024.04.029.


The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy.

Zhang X, Wu X, Li D Int J Mol Sci. 2023; 24(20).

PMID: 37895153 PMC: 10607157. DOI: 10.3390/ijms242015475.


Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis.

Zhao K, Kong C, Shi N, Jiang J, Li P Front Immunol. 2023; 14:1125257.

PMID: 37251412 PMC: 10213547. DOI: 10.3389/fimmu.2023.1125257.


Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation.

Liu T, Zhuang X, Juan Qin X, Bing Wei L, Rong Gao J Front Pharmacol. 2023; 13:1069810.

PMID: 36642989 PMC: 9838551. DOI: 10.3389/fphar.2022.1069810.


References
1.
Narvaez D, Kanitakis J, Faure M, Claudy A . Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol. 1996; 18(3):283-8. DOI: 10.1097/00000372-199606000-00008. View

2.
Aliprantis A, Wang J, Fathman J, Lemaire R, Dorfman D, Lafyatis R . Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A. 2007; 104(8):2827-30. PMC: 1815266. DOI: 10.1073/pnas.0700021104. View

3.
Lafyatis R, York M . Innate immunity and inflammation in systemic sclerosis. Curr Opin Rheumatol. 2009; 21(6):617-22. PMC: 2848972. DOI: 10.1097/BOR.0b013e32832fd69e. View

4.
Ong V, Denton C . Innovative therapies for systemic sclerosis. Curr Opin Rheumatol. 2010; 22(3):264-72. DOI: 10.1097/BOR.0b013e328337c3d6. View

5.
van Lieshout A, Vonk M, Bredie S, Joosten L, Netea M, Van Riel P . Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol. 2009; 38(4):282-90. DOI: 10.1080/03009740802572467. View